Della Rocca has served in a number of CIO positions at Johnson & Johnson, most notably as CIO for the Janssen Pharmaceuticals Americas division since 2019.
“We’re excited about the leadership and experience Chris brings to this role as we continue advancing healthcare through technology,” a company spokesperson said in an email.
EVP and CIO Jim Swanson, who joined J&J in 2019 following positions at Bayer, Monsanto, and Merck, will be Della Rocca’s supervisor.
As operations become increasingly technologically oriented, more companies are increasing the business importance of CIOs. According to ServiceNow statistics, technology executives’ performance is being evaluated in terms of profitability in tandem with the growth of cloud computing.
Johnson & Johnson’s technology leadership has tried to integrate AI into product development and operations.
“The technology is currently being used to help our employees detect disease at earlier stages, accelerate drug discovery, assist with clinical trial recruitment, map a patient’s anatomy before a procedure, and help surgeons predict the best tool for surgery,” Swanson said in a release published last month.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: CIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter
About us:
CIO News is the premier platform dedicated to delivering the latest news, updates, and insights from the CIO industry. As a trusted source in the technology and IT sector, we provide a comprehensive resource for executives and professionals seeking to stay informed and ahead of the curve. With a focus on cutting-edge developments and trends, CIO News serves as your go-to destination for staying abreast of the rapidly evolving landscape of technology and IT. Founded in June 2020, CIO News has rapidly evolved with ambitious growth plans to expand globally, targeting markets in the Middle East & Africa, ASEAN, USA, and the UK.
